News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Year: 2023

Epigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act

Ad-hoc | 20 März 2023 20:19 Epigenomics AG / Key word(s): Change in Forecast/Miscellaneous Epigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act 20-March-2023 / 20:19 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by […]

Read more

Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations)

EQS-News: Epigenomics AG / Key word(s): Miscellaneous/Restructure of Company Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations) 10.03.2023 / 09:37 CET/CEST The issuer is solely responsible for the content of this announcement. Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated […]

Read more

Epigenomics resolves on restructuring to minimize costs

Epigenomics AG / Key word(s): Restructure of Company/Financing ​​​​​​​Epigenomics resolves on restructuring to minimize costs 15-Feb-2023 / 11:13 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG. The issuer is solely responsible for the content of […]

Read more

​​​​​​​Epigenomics decides to restructure to minimize costs

EQS-News: Epigenomics AG / Key word(s): Restructure of Company/Financing​​​​​​​Epigenomics decides to restructure to minimize costs 15.02.2023 / 11:18 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics decides to restructure to minimize costs Berlin (Germany) and San Diego, CA (U.S.A.) February 15, 2023 – The Executive Board of Epigenomics AG (Frankfurt Prime […]

Read more

Epigenomics AG: Resignation of the Chairman of the Supervisory Board Heino von Prondzynski

Berlin, January 27, 2023 -The Chairman of the Supervisory Board of Epigenomics AG, Heino von Prondzynski, informed the Boards today that he will resign from his mandate effective March 31, 2023, for health reasons and will leave the Supervisory Board at that time. Mr. von Prondzynski has been Chairman of the Supervisory Board of Epigenomics […]

Read more

Epigenomics AG: Resignation of Supervisory Board Chairman Heino von Prondzynski

EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Resignation of Supervisory Board Chairman Heino von Prondzynski 27.01.2023 / 18:08 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Resignation of Supervisory Board Chairman Heino von Prondzynski Berlin (Germany), January 27, 2023 -The Chairman of the Supervisory Board of Epigenomics AG (Frankfurt […]

Read more